Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (57)
  • 2024 (43)
  • 2023 (87)
  • 2022 (96)
  • 2021 (81)
  • 2020 (23)
  • 2019 (26)
  • 2018 (6)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Diversion Division (253)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (210)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (371)
  • Pharmaceuticals/Pharmacists/Physicians (227)

Drug Name

  • Oxycodone (88)
  • Opioids (61)
  • Fentanyl (58)
  • Synthetic Opioids (23)
  • Hydromorphone (21)
  • Methamphetamine (15)
  • Benzodiazepines (13)
  • Morphine (11)
  • Cocaine (10)
  • Amphetamines (9)
  • Heroin (6)
  • Methadone (5)
  • Steroids (4)
  • Ketamine (3)
  • Marijuana (Cannabis) (3)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (47)
  • New York (46)
  • St. Louis (43)
  • Atlanta (26)
  • New England (26)
  • Miami (25)
  • Seattle (25)
  • Chicago (24)
  • Sede (24)
  • Dallas (17)
  • El Paso (17)
  • New Jersey (16)
  • Houston (14)
  • San Francisco (13)
  • Louisville (11)
  • Los Angeles (9)
  • New Orleans (9)
  • Omaha (9)
  • Rocky Mountain (8)
  • San Diego (8)
  • Phoenix (7)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
428 Results - Showing 361 to 370
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
PRESS RELEASE

DEA and partners announce results of 20th National Prescription Drug Take Back Day

SEATTLE - DEA’s National Prescription Drug Take Back Day collected 829,543 pounds (419.7 tons) of unused, expired, and unwanted medications across the country. Americans once again showed their dedication toward helping prevent addiction and potential overdose by removing prescription pills from their homes. Our April event included 4,425 community partners...
PRESS RELEASE

Albuquerque company agrees to $240,000 settlement relating to Controlled Substances Act claims

ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Albuquerque Health Services (AHS) has agreed to a $240,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). AHS operates...
PRESS RELEASE

Prison healthcare company agrees to $215,000 settlement relating to Controlled Substances Act claims

ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Centurion Correctional Healthcare New Mexico has agreed to a $215,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). Centurion...
PRESS RELEASE

San Antonio Physician Agrees to Pay $350,000 to Resolve Allegations that he Pre-Signed Prescriptions and Issued Prescriptions Without Appropriate Examinations

SAN ANTONIO - Doctor Hugo A. Rojas, owner of Hugo A. Rojas, M.D., P.A., and Family Clinics of San Antonio, has agreed to pay $350,000.00 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA) and the False Claims Act (FCA), announced Drug...
PRESS RELEASE

Pharmacist Sentenced to More Than 14 Years in Federal Prison for a Drug Distribution Conspiracy and for Murder for Hire

BALTIMORE, Md. – U.S. District Judge George L. Russell, III today sentenced David Robinson, age 51, of Baltimore, Maryland, to 171 months in federal prison, followed by three years of supervised release, for the federal charges of conspiracy to distribute oxycodone and alprazolam and for murder for hire. Robinson, formerly...
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...
PRESS RELEASE

Man from Albuquerque pleads guilty to federal armed robbery of medical products and drug charges

ALBUQUERQUE, N.M. – Joseph Matney, 40, of Albuquerque, New Mexico, pleaded guilty in federal court on Feb. 4 to armed robbery of a pharmacy, theft of medical products and possession with intent to distribute Oxycodone and Alprazolam. According to his plea agreement, Matney entered and robbed an Albuquerque pharmacy on...
PRESS RELEASE

Pharmaceutical Distributor Vistapharm, Inc. Agrees To Pay $325,000 To Resolve Alleged Violations Of The Controlled Substances Act

TAMPA, Fla. - Vistapharm, Inc. has agreed to pay the United States $325,000 to resolve allegations that Vistapharm violated the Controlled Substances Act (CSA) by failing to maintain records required by the CSA. In addition to paying a civil penalty, Vistapharm has agreed to sign separately a Memorandum of Agreement...
PRESS RELEASE

Fond Du Lac, Wisconsin Psychiatrist and Nurse indicted for unlawful distribution of controlled substances

FOND DU LAC, Wis. - Robert J. Bell, Special Agent in Charge, Drug Enforcement Administration (DEA) – Chicago Division and Matthew D. Krueger, U.S. Attorney for the Eastern District of Wisconsin, announced that on January 5, 2021, a federal grand jury indicted John D. Whelan (age: 74), a psychiatrist, and...

Paginación

  • Primera página «
  • Anterior
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Current page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster